罗伊·卡梅隆的演讲。抗体形成的控制:一定的不确定性。

A R Williamson
{"title":"罗伊·卡梅隆的演讲。抗体形成的控制:一定的不确定性。","authors":"A R Williamson","doi":"10.1136/jcp.s3-13.1.76","DOIUrl":null,"url":null,"abstract":"The formation of antibodies has been the subject of hypothesis and experimentation for the whole of this century. Our knowledge of antibody formation has made dramatic advances on several occasions. Many of these advances have become crystallised as certainties in the text books. The fascination of the subject, however, has always been its uncertainties, which have continued to undermine the text book picture of antibody formation. As ever in research, the questions are more important than the answers. For an understanding of antibody formation, or of any other biological system, one must ultimately turn to the molecular level. This necessity was plainly seen by Roy Cameron who, in recreating his research department in 1946, 'determined to explore the new techniques for examination of cell fractions, and lethal syntheses, and biochemical lesions in the cell' (Oakley, 1968). Progress in the study of antibody formation during the past three decades has been achieved by exploring the paths pointed out by Roy Cameron. Those paths have led us well over any horizon that could have been foreseen in 1946 and even beyond horizons visible in 1966. At our present stage in the exploration I will attempt to draw together the apparent certainties and indicate some of the uncertainties. I will begin with the beguiling question of antibody diversity, a subject for which the cellular, genetic, and molecular basis continues to hold many uncertainties.","PeriodicalId":75996,"journal":{"name":"Journal of clinical pathology. Supplement (Royal College of Pathologists)","volume":"13 ","pages":"76-84"},"PeriodicalIF":0.0000,"publicationDate":"1979-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1136/jcp.s3-13.1.76","citationCount":"0","resultStr":"{\"title\":\"Roy Cameron lecture. Control of antibody formation: certain uncertainties.\",\"authors\":\"A R Williamson\",\"doi\":\"10.1136/jcp.s3-13.1.76\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"The formation of antibodies has been the subject of hypothesis and experimentation for the whole of this century. Our knowledge of antibody formation has made dramatic advances on several occasions. Many of these advances have become crystallised as certainties in the text books. The fascination of the subject, however, has always been its uncertainties, which have continued to undermine the text book picture of antibody formation. As ever in research, the questions are more important than the answers. For an understanding of antibody formation, or of any other biological system, one must ultimately turn to the molecular level. This necessity was plainly seen by Roy Cameron who, in recreating his research department in 1946, 'determined to explore the new techniques for examination of cell fractions, and lethal syntheses, and biochemical lesions in the cell' (Oakley, 1968). Progress in the study of antibody formation during the past three decades has been achieved by exploring the paths pointed out by Roy Cameron. Those paths have led us well over any horizon that could have been foreseen in 1946 and even beyond horizons visible in 1966. At our present stage in the exploration I will attempt to draw together the apparent certainties and indicate some of the uncertainties. I will begin with the beguiling question of antibody diversity, a subject for which the cellular, genetic, and molecular basis continues to hold many uncertainties.\",\"PeriodicalId\":75996,\"journal\":{\"name\":\"Journal of clinical pathology. Supplement (Royal College of Pathologists)\",\"volume\":\"13 \",\"pages\":\"76-84\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"1979-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.1136/jcp.s3-13.1.76\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of clinical pathology. Supplement (Royal College of Pathologists)\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1136/jcp.s3-13.1.76\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of clinical pathology. Supplement (Royal College of Pathologists)","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1136/jcp.s3-13.1.76","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Roy Cameron lecture. Control of antibody formation: certain uncertainties.
The formation of antibodies has been the subject of hypothesis and experimentation for the whole of this century. Our knowledge of antibody formation has made dramatic advances on several occasions. Many of these advances have become crystallised as certainties in the text books. The fascination of the subject, however, has always been its uncertainties, which have continued to undermine the text book picture of antibody formation. As ever in research, the questions are more important than the answers. For an understanding of antibody formation, or of any other biological system, one must ultimately turn to the molecular level. This necessity was plainly seen by Roy Cameron who, in recreating his research department in 1946, 'determined to explore the new techniques for examination of cell fractions, and lethal syntheses, and biochemical lesions in the cell' (Oakley, 1968). Progress in the study of antibody formation during the past three decades has been achieved by exploring the paths pointed out by Roy Cameron. Those paths have led us well over any horizon that could have been foreseen in 1946 and even beyond horizons visible in 1966. At our present stage in the exploration I will attempt to draw together the apparent certainties and indicate some of the uncertainties. I will begin with the beguiling question of antibody diversity, a subject for which the cellular, genetic, and molecular basis continues to hold many uncertainties.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Basis of antifibrinolytic therapy. Assessment of inhibitors with chromogenic substrates. Biological role of fibrinolysis. Breakdown products of fibrin and fibrinogen: molecular mechanisms and clinical implications. Biochemistry of the plasmin system.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1